Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure SJ Howard, D Cerar, MJ Anderson, A Albarrag, MC Fisher, ... Emerging infectious diseases 15 (7), 1068, 2009 | 871 | 2009 |
Mechanisms of antifungal drug resistance LE Cowen, D Sanglard, SJ Howard, PD Rogers, DS Perlin Cold Spring Harbor perspectives in medicine 5 (7), a019752, 2015 | 607 | 2015 |
An Outbreak of Phialemonium Infective Endocarditis Linked to Intracavernous Penile Injections for the Treatment of Impotence J Strahilevitz, G Rahav, HJ Schroers, RC Summerbell, Z Amitai, ... Clinical infectious diseases 40 (6), 781-786, 2005 | 377 | 2005 |
Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009 A Bueid, SJ Howard, CB Moore, MD Richardson, E Harrison, P Bowyer, ... Journal of Antimicrobial Chemotherapy 65 (10), 2116-2118, 2010 | 363 | 2010 |
Azole-resistance in Aspergillus: proposed nomenclature and breakpoints PE Verweij, SJ Howard, WJG Melchers, DW Denning Drug Resistance Updates 12 (6), 141-147, 2009 | 307 | 2009 |
Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection SJ Howard, MC Arendrup Medical mycology 49 (Supplement_1), S90-S95, 2011 | 264 | 2011 |
Multi-azole resistance in Aspergillus fumigatus SJ Howard, I Webster, CB Moore, RE Gardiner, S Park, DS Perlin, ... International journal of antimicrobial agents 28 (5), 450-453, 2006 | 240 | 2006 |
Adverse reactions to voriconazole AE Boyd, S Modi, SJ Howard, CB Moore, BG Keevil, DW Denning Clinical infectious diseases 39 (8), 1241-1244, 2004 | 232 | 2004 |
Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance KL Mortensen, RH Jensen, HK Johansen, M Skov, T Pressler, SJ Howard, ... Journal of clinical microbiology 49 (6), 2243-2251, 2011 | 197 | 2011 |
Toxicodynamics of itraconazole: implications for therapeutic drug monitoring JM Lestner, SA Roberts, CB Moore, SJ Howard, DW Denning, WW Hope Clinical infectious diseases 49 (6), 928-930, 2009 | 143 | 2009 |
Getting messier with TIDieR: embracing context and complexity in intervention reporting S Cotterill, S Knowles, AM Martindale, R Elvey, S Howard, N Coupe, ... BMC medical research methodology 18, 1-10, 2018 | 133 | 2018 |
Cryptic species and azole resistance in the Aspergillus niger complex SJ Howard, E Harrison, P Bowyer, J Varga, DW Denning Antimicrobial Agents and Chemotherapy 55 (10), 4802-4809, 2011 | 133 | 2011 |
Differential In Vivo Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and without FKS Resistance Mutations MC Arendrup, DS Perlin, RH Jensen, SJ Howard, J Goodwin, W Hope Antimicrobial agents and chemotherapy 56 (5), 2435-2442, 2012 | 131 | 2012 |
Establishing In Vitro-In Vivo Correlations for Aspergillus fumigatus: the Challenge of Azoles versus Echinocandins MC Arendrup, S Perkhofer, SJ Howard, G Garcia-Effron, A Vishukumar, ... Antimicrobial agents and chemotherapy 52 (10), 3504-3511, 2008 | 123 | 2008 |
EUCAST definitive document e. def 9.3 M Arendrup, J Guinea, M Cuenca-Estrella, J Meletiadis, J Mouton, ... Method for the determination of broth dilution minimum inhibitory …, 2015 | 120 | 2015 |
Pharmacokinetics and pharmacodynamics of posaconazole for invasive pulmonary aspergillosis: clinical implications for antifungal therapy SJ Howard, JM Lestner, A Sharp, L Gregson, J Goodwin, J Slater, ... Journal of Infectious Diseases 203 (9), 1324-1332, 2011 | 117 | 2011 |
EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents MC Arendrup, J Meletiadis, JW Mouton, J Guinea, M Cuenca-Estrella, ... Clinical microbiology and infection 22 (6), 571. e1-571. e4, 2016 | 114 | 2016 |
A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility KL Mortensen, HK Johansen, K Fuursted, JD Knudsen, B Gahrn-Hansen, ... European Journal of Clinical Microbiology & Infectious Diseases 30, 1355-1363, 2011 | 110 | 2011 |
Interrogation of related clinical pan-azole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A … AM Albarrag, MJ Anderson, SJ Howard, GD Robson, PA Warn, ... Antimicrobial agents and chemotherapy 55 (11), 5113-5121, 2011 | 102 | 2011 |
Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis SJ Howard, AC Pasqualotto, DW Denning Clinical Microbiology and Infection 16 (6), 683-688, 2010 | 96 | 2010 |